PCBs directed by Indian Government to fast track environmental clearance for bulk drug projects in India

As per the notification released by the ministry of environment and forest office, the Central Government has decided to fast track the proposals to set up the bulk drug companies and permission of production of bulk drugs in the country and accordingly has asked central pollution control board and all the state pollution control boards to speed up environmental clearances to enable firms to start manufacturing the bulk drugs in the country to meet the growing demand.

As already the imports of APIs and other key starting materials (KSMs) have completely stalled from China the inventory stocks of APIs and other KSMs required for manufacturing medicines stocked by the pharmaceutical manufacturing firms have started fast receding, the central government is mulling various ways and means to ensure adequate bulk drugs and APIs are supplied to the pharmaceutical industries so that there is no dearth of shortage of medicines.
A senior officer from Telangana Pollution Control Board said, “With the novel coronavirus spreading at a faster pace underneath, the central government has decided to take early preparatory steps to ensure adequate bulk drug supplies are available to the pharma firms in the coming days to meet the growing domestic demand. Keeping this in mind the central government has released a notification directing all the pollution control boards to fast tract environmental clearances for all kinds of bulk drug manufacturing proposals within the country,”

“This is a welcome move by the central government. In fact this indication should have been given two years ago by the government, however though late it has come well in time. It may take some time for the bulk drug firms to set up facilities, but overall this decision by the central government is definitely going to boost the bulk drug sector in the coming days,” said P V Appaji, former director general of Pharmexcil.

A ministry official memorandum had also said that the issue has been cleared and will be implemented with immediate effect.

  • Related Posts

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Mumbai Crime Branch cracks down on 5 alleged fake doctors, one found to be only Class 12 pass

    Mumbai Crime Branch cracks down on 5 alleged fake doctors, one found to be only Class 12 pass

    DCA raids med shops for violations over sale of weight-loss drugs

    DCA raids med shops for violations over sale of weight-loss drugs

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event